All In MedTech

FDA Clearance Tracker · P890055-S085

Intera 3000 Hepatic Artery Infusion Pump

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 3, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 3, 2024

Approved

Time to decision

180 days

Received Mar 7, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P890055-S085
Device name
Intera 3000 Hepatic Artery Infusion Pump
Applicant location
Newton, MA
Received
Mar 7, 2024
Decided
Sep 3, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P890055

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

moving the sterilization site for the Tapered Catheter and Intera Oncology office headquarters

Source documents

Other decisions for Intera Oncology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.